rxstat › Shortages › Ceftazidime

Ceftazidime shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Ceftazidime has no current shortage reported in Canada. It has been in shortage before; the history is below.

Products affected

0 / 9

Reports on file

Reports by product

Resolved

CEFTAZIDIME FOR INJECTION BP

6G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437864 · ended Dec 1, 2025 · Disruption of the manufacture of the drug.

Resolved

CEFTAZIDIME FOR INJECTION BP

1G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437848 · ended Oct 7, 2025 · Disruption of the manufacture of the drug.

Resolved

CEFTAZIDIME FOR INJECTION BP

2G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437856 · ended Oct 7, 2025 · Disruption of the manufacture of the drug.

Resolved

CEFTAZIDIME FOR INJECTION BP

6G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437864 · ended Sep 20, 2024 · Delay in shipping of the drug.

Resolved

CEFTAZIDIME FOR INJECTION BP

1G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437848 · ended Feb 13, 2023 · Delay in shipping of the drug.

Resolved

CEFTAZIDIME FOR INJECTION BP

2G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437856 · ended Jul 14, 2022 · Other (Please describe in comments)

Resolved

CEFTAZIDIME FOR INJECTION BP

1G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437848 · ended Jul 11, 2022 · Other (Please describe in comments)

Resolved

CEFTAZIDIME FOR INJECTION BP

6G · POWDER FOR SOLUTION · STERIMAX INC

DIN 02437864 · ended Jul 11, 2022 · Other (Please describe in comments)

Resolved

CEFTAZIDIME FOR INJECTION, USP

2G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD

DIN 00886955 · ended May 19, 2022 · Delay in shipping of the drug.

Resolved

CEFTAZIDIME FOR INJECTION, USP

6G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD

DIN 00886963 · ended May 19, 2022 · Disruption of the manufacture of the drug.

Resolved

CEFTAZIDIME FOR INJECTION, USP

1G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD

DIN 00886971 · ended May 19, 2022 · Disruption of the manufacture of the drug.

Discontinued

FORTAZ

2G · POWDER FOR SOLUTION · GLAXOSMITHKLINE INC

DIN 02212226

Showing 12 of 21 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Ceftazidime. Health Canada has 21 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Ceftazidime is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DD).

Recent changes

No changes recorded yet.

Common questions

When will Ceftazidime be back in stock in Canada?

Ceftazidime has no active shortage; supply is normal per Health Canada reports.

Why is Ceftazidime in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other beta-lactam antibacterials)

Widespread shortageCefaclor5 of 5 reported products affected Widespread shortageCefazolin1 of 13 reported products affected Widespread shortageCefepime2 of 3 reported products affected · est. return May 29, 2026 Partial shortageCefixime1 of 4 reported products affected · est. return Jul 10, 2026 Partial shortageCefprozil1 of 16 reported products affected Partial shortageCeftriaxone1 of 15 reported products affected · est. return Jun 15, 2026

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.